How to Help Your Patients Find Daysee 91 Day in Stock: A Provider's Guide

Your Patients Can't Find Their Birth Control — Here's How You Can Help

As a prescriber, you've likely heard this from patients more than once: "My pharmacy says they don't have my birth control." For patients on Daysee 91 Day — an extended-cycle oral contraceptive with a 91-day dosing schedule — pharmacy stock-outs can be particularly disruptive. Unlike a standard 28-day pack, missing doses of a 91-day regimen can compromise months of uninterrupted contraceptive coverage.

This guide provides a practical framework for helping your patients locate Daysee 91 Day (Levonorgestrel 0.15 mg / Ethinyl Estradiol 0.03 mg, 84 tablets + Ethinyl Estradiol 0.01 mg, 7 tablets) or transition to an equivalent product when their usual pharmacy comes up empty.

Current Availability Landscape

Daysee 91 Day, manufactured by Lupin Pharmaceuticals, is not in a formal FDA-reported shortage as of 2026. The product remains commercially available, and multiple AB-rated generics exist on the market.

The availability challenge is driven primarily by pharmacy stocking patterns rather than manufacturing supply issues:

• Extended-cycle OCs represent a small fraction of total oral contraceptive dispensing volume
• Many pharmacy locations stock only the generic their primary wholesaler carries or their most-dispensed version
• Insurance formulary preferences vary, creating mismatches between prescribed products and stocked products
• Chain pharmacy inventory systems may deprioritize low-volume SKUs

For the full availability briefing, see: Daysee 91 Day Shortage: What Providers Need to Know.

Why Patients Can't Find Daysee 91 Day

When a patient reports they can't fill their Daysee prescription, the root cause usually falls into one of these categories:

The Pharmacy Doesn't Stock It

This is the most common scenario. The pharmacy either doesn't carry any extended-cycle OC or carries a different generic version. The patient hears "we don't have it" and assumes there's a shortage, when the reality is a stocking gap.

Insurance Requires a Different Product

The patient's insurance formulary may designate a specific generic (e.g., Camrese or Ashlyna) as the preferred product. If the prescription is written for Daysee, the pharmacy may need to contact your office for authorization to substitute, creating a delay.

The Prescription Says "Dispense As Written"

If the prescription carries a DAW designation, the pharmacy cannot substitute even if an equivalent product is on the shelf. This is easily resolved by updating the prescription.

The Patient Waited Too Long to Refill

Patients on 91-day cycles may not realize they need to start the refill process earlier than they would with a 28-day pack. By the time they try to fill, the pharmacy needs to order the product and the patient has a gap in coverage.

What Providers Can Do: 5 Practical Steps

Step 1: Prescribe for Maximum Fill Flexibility

Write the prescription by generic name (Levonorgestrel/Ethinyl Estradiol extended-cycle) and allow substitution. This single step eliminates most pharmacy-level fill failures. If your EHR defaults to a specific brand, override it or add a note allowing therapeutic substitution.

Step 2: Verify the Patient's Formulary

Before the patient leaves your office, check their insurance formulary (through your EHR, the plan's provider portal, or a real-time benefit check tool) to determine which extended-cycle OC is the preferred product. Prescribing the formulary-preferred generic eliminates prior auth requirements and reduces cost.

Step 3: Recommend Availability Search Tools

Direct patients to Medfinder for Providers — or use it yourself in the office — to identify pharmacies near the patient that have the prescribed product in stock. This is especially valuable when the patient's regular pharmacy is out.

You can also share the patient-facing version at medfinder.com so patients can search on their own for future refills.

Step 4: Set Up Proactive Refill Reminders

Encourage patients to start the refill process at least 7–10 days before their current pack runs out. Many pharmacies can set up automatic refills. For patients who use mail-order pharmacy, recommend enrolling in auto-ship programs to ensure uninterrupted delivery.

Step 5: Have a Backup Plan Ready

For patients who experience repeated difficulty finding extended-cycle OCs, discuss backup strategies during the initial prescribing visit:

• Continuous use of a monophasic 28-day OC: Prescribe a standard Levonorgestrel/EE pill (widely available) with instructions to skip placebo weeks. This achieves similar cycle suppression using a more commonly stocked product.
• Alternative extended-cycle formulations: LoSeasonique/Camrese Lo (lower dose) or Quartette (escalating dose) may be more readily available in some markets.
• Non-oral contraceptive methods: For patients who struggle with daily adherence over 91 days, consider the patch, ring, or LARC methods.

Therapeutic Alternatives at a Glance

When switching from Daysee 91 Day, these are the most straightforward substitutions:

• Direct generics (same formulation): Camrese, Ashlyna, Simpesse, Jaimiess, Rivelsa, Fayosim
• Same active ingredients, different end-of-cycle design: Amethia, Jolessa (use inert placebo tablets instead of low-dose EE during the 7-day break)
• Lower-dose option: LoSeasonique / Camrese Lo (Levonorgestrel 0.1 mg / EE 0.02 mg)
• Escalating-dose option: Quartette

For a patient-facing comparison of alternatives, direct patients to: Alternatives to Daysee 91 Day.

Workflow Tips for Your Practice

• Build a formulary cheat sheet: For the top 3–5 insurance plans your practice sees most, identify the preferred extended-cycle OC for each. Keep this accessible at the prescribing station.
• Use e-prescribing with real-time formulary checks: Most modern EHR systems can check formulary status at the point of prescribing. Use this feature to avoid write-backs and delays.
• Designate a staff member for pharmacy liaison: When patients call reporting fill issues, having one team member who handles pharmacy communication can resolve problems faster.
• Include Medfinder in your patient handouts: Add medfinder.com/providers to your printed or digital discharge instructions for patients on extended-cycle contraceptives.
• Document therapeutic substitution agreements: If a patient consents to receiving any AB-rated equivalent, document this in the chart. This streamlines future pharmacy interactions.

Cost Considerations for Your Patients

For patients without insurance or with high-deductible plans:

• Generic extended-cycle OCs cost as little as $27–$60 per 91-day pack with discount coupons (GoodRx, SingleCare)
• Brand Daysee cash price is approximately $200–$300 per pack
• Lupin Pharmaceuticals Patient Assistance Program may provide free medication to qualifying uninsured patients (accessible through NeedyMeds or RxAssist)
• Under the ACA, insured patients should have $0 copay for at least one covered extended-cycle OC

Direct patients who need help with cost to: How to Save Money on Daysee 91 Day. For the provider perspective on cost navigation, see: How to Help Patients Save Money on Daysee 91 Day.

Final Thoughts

Pharmacy stock-outs for Daysee 91 Day are a logistics problem, not a supply shortage — and logistics problems have logistics solutions. By prescribing flexibly, verifying formularies proactively, and connecting patients with availability tools like Medfinder for Providers, you can help ensure your patients maintain uninterrupted access to their extended-cycle contraception.

The goal is simple: no patient should miss a dose of their birth control because of a pharmacy stocking gap.